Stokes2020 - Antibiotics discovery using deep learning approach (Antiviral implementation)

This model was developed to support the early efforts in the identification of novel drugs against SARS-CoV2. It predicts the probability that a small molecule inhibits SARS-3CLpro-mediated peptide cleavage. It was developed using a high-throughput screening against the 3CL protease of SARS-CoV1, as no data was yet available for the new virus (SARS-CoV2) causing the COVID-19 pandemic. It uses the ChemProp model.

Model Type: Predictive machine learning model.
Model Relevance: Probability of 3CL protease inhibition.
Model Encoded by: Miquel Duran-frigola (Ersilia)
Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam

Implementation of this model code by Ersilia is available here:
https://github.com/ersilia-os/eos9f6t